Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9241 |
High Similarity |
NPD4584 |
Approved |
0.9225 |
High Similarity |
NPD4664 |
Clinical (unspecified phase) |
0.8846 |
High Similarity |
NPD4010 |
Discontinued |
0.8816 |
High Similarity |
NPD7298 |
Approved |
0.875 |
High Similarity |
NPD4772 |
Phase 2 |
0.875 |
High Similarity |
NPD4773 |
Phase 2 |
0.8609 |
High Similarity |
NPD3641 |
Approved |
0.8609 |
High Similarity |
NPD3639 |
Approved |
0.8609 |
High Similarity |
NPD3640 |
Phase 3 |
0.8598 |
High Similarity |
NPD8053 |
Approved |
0.8598 |
High Similarity |
NPD8054 |
Approved |
0.8497 |
Intermediate Similarity |
NPD4017 |
Approved |
0.8481 |
Intermediate Similarity |
NPD7201 |
Clinical (unspecified phase) |
0.84 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.8385 |
Intermediate Similarity |
NPD2898 |
Approved |
0.8355 |
Intermediate Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD2421 |
Approved |
0.8289 |
Intermediate Similarity |
NPD2420 |
Approved |
0.828 |
Intermediate Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.8247 |
Intermediate Similarity |
NPD6031 |
Approved |
0.8247 |
Intermediate Similarity |
NPD6030 |
Approved |
0.8239 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.8239 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.8224 |
Intermediate Similarity |
NPD3845 |
Phase 1 |
0.8171 |
Intermediate Similarity |
NPD8252 |
Approved |
0.8171 |
Intermediate Similarity |
NPD8251 |
Approved |
0.8171 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.816 |
Intermediate Similarity |
NPD27 |
Approved |
0.816 |
Intermediate Similarity |
NPD2489 |
Approved |
0.8138 |
Intermediate Similarity |
NPD2669 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.8121 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.8105 |
Intermediate Similarity |
NPD2422 |
Clinical (unspecified phase) |
0.8086 |
Intermediate Similarity |
NPD6107 |
Approved |
0.8082 |
Intermediate Similarity |
NPD5718 |
Phase 2 |
0.8052 |
Intermediate Similarity |
NPD3124 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7988 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7988 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7947 |
Intermediate Similarity |
NPD1632 |
Clinical (unspecified phase) |
0.7927 |
Intermediate Similarity |
NPD3051 |
Approved |
0.7927 |
Intermediate Similarity |
NPD4166 |
Phase 2 |
0.7917 |
Intermediate Similarity |
NPD6297 |
Approved |
0.7892 |
Intermediate Similarity |
NPD5602 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7802 |
Discontinued |
0.784 |
Intermediate Similarity |
NPD6788 |
Approved |
0.7838 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7838 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7823 |
Intermediate Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.7818 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD6896 |
Approved |
0.7815 |
Intermediate Similarity |
NPD6895 |
Approved |
0.7803 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5313 |
Approved |
0.7798 |
Intermediate Similarity |
NPD5312 |
Approved |
0.7792 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7792 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7778 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7778 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7778 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6853 |
Approved |
0.7733 |
Intermediate Similarity |
NPD6851 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2978 |
Approved |
0.7716 |
Intermediate Similarity |
NPD2977 |
Approved |
0.7674 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7674 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7647 |
Intermediate Similarity |
NPD1753 |
Discontinued |
0.7644 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7643 |
Intermediate Similarity |
NPD6783 |
Clinical (unspecified phase) |
0.7619 |
Intermediate Similarity |
NPD3053 |
Approved |
0.7619 |
Intermediate Similarity |
NPD3055 |
Approved |
0.7616 |
Intermediate Similarity |
NPD8453 |
Clinical (unspecified phase) |
0.7616 |
Intermediate Similarity |
NPD3110 |
Approved |
0.7616 |
Intermediate Similarity |
NPD3109 |
Approved |
0.758 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD5084 |
Clinical (unspecified phase) |
0.7578 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD4162 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7561 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7542 |
Intermediate Similarity |
NPD7667 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD4581 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD4481 |
Phase 3 |
0.7514 |
Intermediate Similarity |
NPD2490 |
Approved |
0.7514 |
Intermediate Similarity |
NPD2488 |
Approved |
0.75 |
Intermediate Similarity |
NPD6090 |
Discontinued |
0.7485 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7485 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2028 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7469 |
Intermediate Similarity |
NPD824 |
Approved |
0.7456 |
Intermediate Similarity |
NPD6688 |
Approved |
0.7456 |
Intermediate Similarity |
NPD6687 |
Approved |
0.7453 |
Intermediate Similarity |
NPD2122 |
Discontinued |
0.7452 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7452 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7448 |
Intermediate Similarity |
NPD2667 |
Approved |
0.7448 |
Intermediate Similarity |
NPD2668 |
Approved |
0.7438 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.7434 |
Intermediate Similarity |
NPD4474 |
Approved |
0.7434 |
Intermediate Similarity |
NPD4475 |
Approved |
0.7429 |
Intermediate Similarity |
NPD6618 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7417 |
Intermediate Similarity |
NPD5156 |
Approved |
0.7417 |
Intermediate Similarity |
NPD5155 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2232 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2233 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2230 |
Approved |
0.7414 |
Intermediate Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.7405 |
Intermediate Similarity |
NPD6658 |
Clinical (unspecified phase) |
0.74 |
Intermediate Similarity |
NPD3636 |
Approved |
0.74 |
Intermediate Similarity |
NPD3635 |
Approved |
0.74 |
Intermediate Similarity |
NPD3637 |
Approved |
0.7379 |
Intermediate Similarity |
NPD4093 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD7598 |
Phase 2 |
0.7371 |
Intermediate Similarity |
NPD7280 |
Phase 3 |
0.7371 |
Intermediate Similarity |
NPD5917 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD7281 |
Phase 3 |
0.7358 |
Intermediate Similarity |
NPD3692 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD2606 |
Approved |
0.7351 |
Intermediate Similarity |
NPD2605 |
Approved |
0.7351 |
Intermediate Similarity |
NPD3595 |
Approved |
0.7351 |
Intermediate Similarity |
NPD3594 |
Approved |
0.7346 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD7945 |
Clinical (unspecified phase) |
0.7329 |
Intermediate Similarity |
NPD1424 |
Approved |
0.7325 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7322 |
Intermediate Similarity |
NPD8095 |
Phase 1 |
0.7317 |
Intermediate Similarity |
NPD6875 |
Approved |
0.7317 |
Intermediate Similarity |
NPD6876 |
Approved |
0.7315 |
Intermediate Similarity |
NPD7258 |
Clinical (unspecified phase) |
0.7315 |
Intermediate Similarity |
NPD5311 |
Approved |
0.7315 |
Intermediate Similarity |
NPD5310 |
Approved |
0.7303 |
Intermediate Similarity |
NPD7291 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD6748 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.729 |
Intermediate Similarity |
NPD823 |
Approved |
0.729 |
Intermediate Similarity |
NPD4579 |
Clinical (unspecified phase) |
0.729 |
Intermediate Similarity |
NPD817 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5773 |
Approved |
0.7289 |
Intermediate Similarity |
NPD5772 |
Approved |
0.7284 |
Intermediate Similarity |
NPD3647 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7045 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7262 |
Intermediate Similarity |
NPD5604 |
Discontinued |
0.7251 |
Intermediate Similarity |
NPD4083 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7243 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7243 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7243 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7243 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7241 |
Intermediate Similarity |
NPD7479 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD7905 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7215 |
Intermediate Similarity |
NPD3656 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7212 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7208 |
Intermediate Similarity |
NPD554 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7192 |
Intermediate Similarity |
NPD2226 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD5087 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD3977 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD228 |
Approved |
0.7176 |
Intermediate Similarity |
NPD5677 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD7153 |
Discontinued |
0.7161 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7161 |
Intermediate Similarity |
NPD3062 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7161 |
Intermediate Similarity |
NPD3059 |
Approved |
0.7161 |
Intermediate Similarity |
NPD3061 |
Approved |
0.7152 |
Intermediate Similarity |
NPD4103 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD4104 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD4098 |
Discontinued |
0.7152 |
Intermediate Similarity |
NPD2161 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5160 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3920 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD6812 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4659 |
Approved |
0.7128 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7128 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7126 |
Intermediate Similarity |
NPD5720 |
Discontinued |
0.7126 |
Intermediate Similarity |
NPD5708 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD44 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6364 |
Approved |
0.7108 |
Intermediate Similarity |
NPD1337 |
Clinical (unspecified phase) |
0.7097 |
Intermediate Similarity |
NPD1132 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1136 |
Approved |
0.7097 |
Intermediate Similarity |
NPD1130 |
Approved |
0.7097
|
Intermediate Similarity |
NPD6612 |
Phase 2 |